Observational study of COVID-19 vaccine responses in patients with autoimmune diseases
Brief description of study
Adult patients with Rheumatoid Arthritis, Psoriatic Arthritis, SLE, Sjogren’s Disease, Multiple Sclerosis, Scleroderma, Vasculitis or Blistering Diseases will undergo a blood draw and collection of clinical information prior to receipt of COVID-19 vaccination. Subjects will undergo a repeat blood draw and collection of clinical information at 4-10 weeks, 6 months and 12 months following their second vaccination (or 8-12 weeks after single vaccination for vector based vaccine).
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Rheumatoid Arthritis, Psoriatic Arthritis, SLE, Sjogren’s Disease, Multiple Sclerosis, Scleroderma, Vasculitis or Blistering Diseases
-
Age: Between 18 Years - 99 Years
-
Gender: All
Male or Female, Age 18 or older, Obtaining Covid-19 vaccine.
Updated on
17 Oct 2023.
Study ID: 850219
